Tag: Pharma business news
Takeda offers $62bn to acquire Irish rare disease company Shire
Japanese pharma company Takeda Pharmaceutical has proposed to acquire Shire, an Ireland-based rare disease company for $62 billion after Botox-maker Allergan scrapped its plans of ... Read More
Procter & Gamble to acquire Merck’s consumer health business for €3.4bn
P&G acquisition of Merck consumer health business : US consumer goods company Procter & Gamble (P&G) has agreed to acquire German pharma company Merck’s consumer ... Read More
French pharma company Servier to acquire Shire oncology business for $2.4bn
Pharma acquisition news : French pharma company Servier Laboratories has made a $2.4 billion all-cash deal to acquire the oncology business of Irish biotech company ... Read More
Sanofi announces $396m vaccine manufacturing facility in Toronto
French pharma company Sanofi has announced a new vaccine manufacturing facility in Toronto to be built with an investment of CAD500 million ($396.3 million) at ... Read More
Alexion to acquire Swedish pharma company Wilson Therapeutics for $855m
Pharma acquisition news : US-based Alexion Pharmaceuticals through an all-cash deal of SEK7.1 billion ($855 million) will acquire Wilson Therapeutics, a Swedish pharma company focused ... Read More
GSK offloads rare disease gene therapy drugs to Orchard Therapeutics
Pharma acquisition news : British drug company GlaxoSmithKline (GSK) has agreed to transfer its rare disease gene therapy drugs to Orchard Therapeutics for an equity ... Read More
Novartis to buy US gene therapy company AveXis for $8.7bn
Novartis acquisition of AveXis : Swiss pharma company Novartis has struck a $8.7 billion deal to acquire US gene therapy company AveXis in a move ... Read More
GSK to buy out Novartis’ stake in consumer healthcare JV for $13bn
Pharma acquisition news : GlaxoSmithKline (GSK) has agreed to buy out Swiss pharma company Novartis’ stake of 36.5% in their consumer healthcare joint venture (JV) ... Read More
GSK, Reckitt Benckiser pull out from $20bn race to acquire Pfizer’s consumer healthcare business
Pharma acquisition news : In a blow to Pfizer’s plans to offload its consumer healthcare business for about $20 billion, both Reckitt Benckiser and now ... Read More
Danish pharma company Lundbeck to buy Parkinson’s drug developer Prexton
Pharma acquisition news : Danish pharma company Lundbeck has reached an agreement, expected to be worth around $1.1 billion, to acquire Prexton Therapeutics, a Swiss ... Read More